Clinical Trials Directory

Trials / Unknown

UnknownNCT02123771

Gamma-Glutamyl Transpeptidase (GGT): A Potential Diagnostic Marker for Helicobacter Pylori Infections

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
National University Hospital, Singapore · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Accepted

Summary

The investigators hypothesis: Presence of anti-GGT (antibody against GGT) indicates H. pylori infection.

Detailed description

Subjects will be requested to provide 1-5g of their solid/semi-solid stool sample, to be collected within 24 hours prior to their scheduled visit for urea breath test. Patients should not have been treated for H. pylori prior to stool collection. Stool samples will be tested using ELISA for the presence of the H. pylori GGT antigen using monoclonal antibodies against GGT. Stool samples will also be tested for the presence of H. pylori DNA using PCR and Western blot analysis respectively. Presence of the GGT antigen in stool will be compared between H. pylori-positive and H. pylori-negative patients. Rapid urease test results will be used as the gold standard of H. pylori diagnosis. The sensitivity and specificity of the stool antigen test will be established.

Conditions

Timeline

Start date
2013-05-01
Primary completion
2014-03-01
First posted
2014-04-28
Last updated
2014-04-28

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT02123771. Inclusion in this directory is not an endorsement.

Gamma-Glutamyl Transpeptidase (GGT): A Potential Diagnostic Marker for Helicobacter Pylori Infections (NCT02123771) · Clinical Trials Directory